glp 1 gerd For patients taking GLP-1 receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research presented at the Potential Use of GLP-1 and
Description
Over the last few years, the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for managing type 2 diabetes has dramatically increased
But losing more than 1.5%2% of body weight per week raises the risk of muscle and bone loss
PPIs help reduce the amount of acid the stomach makes
It highlights the confusion here
Ishii M, Nakamura T, Kasai F, Onuma T, Baba T, Takebe K
Al ralentizar el vaciamiento gstrico, el paciente se siente saciado antes y durante ms tiempo
